INTRODUCTION AND OBJECTIVES: Kidney stone disease (KSD) is a common urological disorder in the United States with a prevalence of 11% and 7% in men and women, respectively. Several factors are known to increase an individual's risk for KSD including obesity, diabetes, metabolic syndrome and poor nutrition; interestingly, each of these factors has a well-documented association with the human gut microbiome both in terms of taxonomic composition and metabolic capacity. In this study we applied high-resolution gut microbiome analysis to identify significant shifts in bacterial species composition and associated functional gene content between kidney stone formers and non-stone forming controls.
METHODS: 16S rRNA amplicon sequences generated by the Illumina MiSeq platform were filtered for quality and contaminants, and subsequently analyzed using the Resphera Insight algorithm for highresolution taxonomic assignment. Species abundances were then assessed for significant enrichment or depletion in stone formers relative to controls utilizing the negative binomial test followed by False Discovery Rate p-value adjustment. Functional gene content was also assessed with PICRUSt.
RESULTS: A total of 23 patients with KSD and six non-stoneforming controls maintained an average of 3,893 sequences per sample. Species-level profiling with Resphera Insight revealed significantly different levels of several species including 90% reductions of Prevotella buccalis and Prevotella corporis in the KSD group (adj.P<0.01). We also observe relative increases of Bacteroides and Clostridia species in KSD patients including a 27-fold increase in Bacteroides acidifaciens (adj.P¼1e-6), and a 40-fold increase in Clostridium ramosum (adj.P¼6e-12). Functional characterization identified KEGG pathways enriched in KSD relative to controls, including primary and secondary bile acid synthesis (P¼0.001), a 3-fold increase in steroid hormone synthesis (P¼0.007), as well as fructose metabolism, galactose metabolism and glycosaminoglycan degradation.
CONCLUSIONS: KSD patients maintain significantly higher levels of specific Bacteroides and Clostridia species and significantly lower Prevotella species as compared to controls. Enrichments in multiple categories of metabolism were also identified. The gut microbiome may interact with kidney stone formation and identification of pathways and species level bacteria may allow for directed studies that will in the future build upon these findings.
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MP19-02 SALIVARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AND CORTISOL MEASUREMENT IN ACUTE RENAL COLIC
Ashraf Tamimi*, Eyal Kord, Yishai Rapaport, Ramziya Abu hamad, Shai Efrati, Amnon Zisman, Yoram Siegel, zrifin, Israel INTRODUCTION AND OBJECTIVES: Introduction: In acute ureteral stone obstruction the decision to treat is sometimes missing a forecaster for a better outcome. Neutrophil Gelatinase-Associated Lipocalin (NGAL) levels are predictive biomarker of Acute Kidney Injury (AKI) with correlation to complication and survival in major surgery. NGAL is particularly expressed during the first 24 hours in the proximal tubules. Cortisol levels in saliva found to be a reliable parameter for stress. Salivary levels of NGAL during renal colic were not evaluated so far. OBJECTIVE To measure salivary NGAL and Cortisol levels in patients presented to the Emergency Room (ER) with acute renal colic.
METHODS: Prospective controlled study of all patients who presented to ER with acute renal colic and diagnosed with single ureteric stone obstruction by non-contrast computed tomography (NCCT). Saliva, urine and blood samples were collected in patients and control group during the first morning of admission. Salivent system was used to collect the salivary samples for Human Lipocalin-2/NGAL Quantikine ELISA Kit test and for Cortisol. A questionnaire was used to evaluate patient's repose, and clinical data were collected.
RESULTS: 44 patients in the study group, 13 in the control group, mean age 48AE13 years, BMI 28AE6, mean stone size 6AE4 mm, mean VAS scored of 7AE2, mean creatinine levels of 1.3AE0.3 mgr/dl, mean WBC 10,900AE3,100 count per field, CRP 29AE55 .23 (53%) of patient underwent urgent intervention. Serum (199AE154 vs 81AE24, p < 0.001) and, predominantly Salivary (474AE185 vs 328AE134; p < 0.05) NGAL levels were significantly elevated in patients with acute renal colic in comparison to controls. Cortisol level on the contrary did not demonstrate any increase during acute phase of renal colic, suggestive a delay response or suppression mechanism.
CONCLUSIONS: Salivary and blood NGAL sampling is feasible during acute phase of renal colic. High levels of salivary NGAL are observed in a single sampling during acute ureteral stone obstruction and may advance clinical decision making. Cortisol levels fail to increased suggestive of some suppression mechanism. Recent studies have demonstrated associations between nephrolithiasis and systemic conditions, including low bone mineral density (BMD), which may be correlated to hypercalciuria in these kidney stone formers (KSF). Traditionally, low bone mineral density is diagnosed with dual-energy x-ray absorptiometry. Our objective was to evaluate the association of CT-based vertebral bone mineral density with 24-hour urine parameters in KSF METHODS: This is a retrospective analysis of 99 kidney stone formers who had CT imaging and 24-hour urine studies at our institution. For each patient, BMD was estimated by placing an oval region of interest on an area of vertebral body trabecular bone at the L1 level and CT attenuation measured in Hounsfield units (HU). From established data, a threshold for a balanced sensitivity (73.9%) and specificity (70.6%) of 160 HU was chosen to distinguish normal from low BMD. Patient demographics, serum chemistry, and 24-hour urine parameters were collected for each patient. Univariate and multivariate logistic regression analysis was performed to compare patients with low and normal BMD. Multivariate linear regression was Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e229
